P529: FIRST EUROPEAN REAL-WORLD EVIDENCE PROSPECTIVE REGISTRY OF FIRST-LINE ADULT PATIENTS WITH BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM TREATED WITH FIRST-IN-CLASS CD123-TARGETED THERAPY TAGRAXOFUSP

• U. Platzbecker,
• E. Angelucci,
• P. Montesinos,
• R. M. Lemoli,
• A. Spyridonidis,
• J. Casariego,
• T. I. Mughal,
• M. Mohty

Affiliations

U. Platzbecker

1 Medical Clinic and Policlinic of Hematology, Cell Therapy and Hemostaseology, University Hospital Leipzig, Leipzig, Germany

E. Angelucci

2 Hematology and Cellular Therapy Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy

P. Montesinos

3 Department of Hematology, Hospital Universitari i Politècnic La Fe, València, Spain

R. M. Lemoli

4 Clinic of Hematology, Department of Internal Medicine, IRCCS San Martino Hospital, University of Genoa, Genoa, Italy

A. Spyridonidis

5 Department of Internal Medicine, BMT Unit, University of Patras, Patras, Greece

J. Casariego

6 Aldebaran Research & Development SL, Madrid, Spain

T. I. Mughal

7 Division of Hematology-Oncology, Tufts University School of Medicine, Boston

M. Mohty

9 Department of Hematology and Cellular Therapy, Hôpital Saint-Antoine, Sorbonne University, Paris, France